GSK (GSK) – Downgrades
-
GSK (GSK) risk-reward attractive, AstraZeneca (AZN) needs margin clarity - Jefferies
-
JPMorgan Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Underweight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GSK Stock Lookup